|This article is an orphan, as no other articles link to it. Please introduce links to this page from ; try the Find link tool for suggestions. (February 2009)|
Proteogenix is a corporation based in Portland, Oregon, United States, that develops and markets biomarker diagnostic tests for the detection of life-threatening pregnancy-related conditions. Proteogenix is currently developing non-invasive protein biomarker screening tests for intra-amniotic infection, premature birth, and Down syndrome, which combined cause 175,000 premature births each year in the United States alone.
- "ProteoGenix News from The BioSpace Beat". Biospace.com. September 29, 2004.